{
    "study_accession": "SDY7",
    "actual_completion_date": null,
    "actual_enrollment": 90,
    "actual_start_date": "2008-04-01",
    "age_unit": "Years",
    "brief_description": "To measure total and specific antibody titers and T cell responses in a sample of subjects who experienced eczema vaccinatum (EV) and a group of subjects who did not suffer from EV (normal controls or healthy AD subjects).",
    "brief_title": "ADVN Biomarker Registry Study: CMI/Ab-Vaccinia Substudy",
    "clinical_trial": "Y",
    "condition_studied": "Atopic Dermatitis Eczema Vaccinatum            ",
    "dcl_id": 2,
    "description": "To measure total and specific antibody titers and T cell responses in a sample of subjects who experienced eczema vaccinatum (EV) and a group of subjects who did not suffer from EV (normal controls or healthy AD subjects).",
    "doi": "10.21430/M3G81PA5G7",
    "endpoints": "<ol type=1><li>Total antibodies (ELISA)</li><li>Total vaccinia-specific antibodies (ELISA)</li><li>Neutralizing antiviral serum vaccinia-specific antibodies (plaque reduction assay)</li><li>Vaccinia-specific memory B-cells (limiting dilution analysis)</li><li>IFN&gamma; production by vaccinia-specific CD4+ T cells</li><li>IFN&gamma; production by vaccinia-specific CD8+ T cells</li><li>IFN&gamma; production by vaccinia-specific NK T cells</li><li>CD3 cytokine responses from Memory T cells (Pos Control)</li><li>Antigen specific antibody levels: diphtheria</li><li>Antigen specific antibody levels: tetanus</li><li>Antigen specific antibody levels: pertussis</li><li>Antigen specific antibody levels: measles</li><li>Antigen specific antibody levels: mumps</li><li>Antigen specific antibody levels: rubella</li><li>Antigen specific antibody levels: polio</li><li>Antigen specific antibody levels: varicella</li><li>Antigen specific antibody levels: Epstein-Barr</li><li>Antigen specific antibody levels: cytomegalovirus</li><li>Total IgE</li></ol>",
    "gender_included": "Female, Male",
    "hypothesis": "EV patients have a deficit in their virus-specific antibody or T cell responses following smallpox vaccination and this will be apparent when compared to age/sex-matched subjects who did not experience a severe adverse event following smallpox vaccination.",
    "initial_data_release_date": "2012-11-16",
    "initial_data_release_version": "DR1",
    "intervention_agent": "NA\r",
    "latest_data_release_date": "2017-04-21",
    "latest_data_release_version": "DR21",
    "maximum_age": "  74.00",
    "minimum_age": "  16.00",
    "objectives": "To measure Vaccinia antibody titers and T cell responses in subjects who experienced EV and a group of subjects who did not suffer from EV (NA controls or AD subjects).",
    "official_title": "ADVN Biomarker Registry Study: CMI/Ab-Vaccinia Substudy",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 67,
    "workspace_id": 1089,
    "research_focus": [
        "Atopy/Allergy"
    ],
    "arm": [
        {
            "arm_accession": "ARM259",
            "description": "Atopic Dermatitis subjects with previous or current EV eczema vaccinatum after smallpox vaccination.",
            "name": "AD+ EV+ with vaccination"
        },
        {
            "arm_accession": "ARM260",
            "description": "Atopic Dermatitis subjects with no EV after smallpox vaccination.",
            "name": "AD+ EV- with vaccination"
        },
        {
            "arm_accession": "ARM261",
            "description": "Nonatopic/healthy subjects and no eczema vaccinatum after smallpox vaccination.",
            "name": "Healthy controls with vaccination"
        },
        {
            "arm_accession": "ARM262",
            "description": "Atopic Dermatitis subjects, no smallpox vaccinations.",
            "name": "AD+ no vaccination"
        }
    ],
    "personnel": [
        {
            "first_name": "Donald",
            "last_name": "Leung",
            "organization": "National Jewish Health",
            "role_in_study": "Principal Investigator",
            "site_name": "National Jewish Health\r"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Atopic Dermatitis & Vaccinia Network (ADVN)",
            "contract_name": "Atopic Dermatitis and Vaccinia Network (ADVN) Clinical Studies Consort-26629c"
        }
    ],
    "assay": [],
    "subject": {
        "race": [
            {
                "race": "Black or African American",
                "count": 6
            },
            {
                "race": "Other",
                "count": 8
            },
            {
                "race": "White",
                "count": 76
            }
        ],
        "gender": [
            {
                "Female": 58
            },
            {
                "Male": 32
            }
        ]
    }
}
